Molecular Devices designs, engineers, and commercializes scientific instruments, software, and reagents for a wide range of bioanalyses to support basic life sciences research, drug discovery and development, and biotest and bioassay design.
With headquarters in Silicon Valley and regional as well as country offices around the world, we are dedicated to supporting and enriching the research efforts of the international BioResearch, BioPharma, and BioTesting communities.
Although we produce our corporate website in English, we maintain Business Overview sections in French, German, Italian, Portuguese, and Spanish. In addition, our offices in Japan and China maintain local language websites that are independent from the corporate site.
Founded in 1983, Molecular Devices introduced its first Microplate Reader in 1987 and since then has continued to broaden its offerings of bioanalytical systems for life science and drug discovery research through a combination of internal R&D and strategic acquisitions.
Molecular Devices provides one of the widest ranges of bioanalytical systems for life science and drug discovery research available from a single supplier. Our systems are built on proprietary technology platforms that deliver high performance, flexibility, and reliability. Some of our key patented technologies are listed below. For more information about any of these technologies, please contact us directly.